These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 2537138)
41. SV40 small t antigen enhances the transformation activity of limiting concentrations of SV40 large T antigen. Bikel I; Montano X; Agha ME; Brown M; McCormack M; Boltax J; Livingston DM Cell; 1987 Jan; 48(2):321-30. PubMed ID: 3026642 [TBL] [Abstract][Full Text] [Related]
42. Converting the JCV T antigen Rb binding domain to that of SV40 does not alter JCV's limited transforming activity but does eliminate viral viability. Tavis JE; Trowbridge PW; Frisque RJ Virology; 1994 Mar; 199(2):384-92. PubMed ID: 8122368 [TBL] [Abstract][Full Text] [Related]
43. Suppression of the simian virus 40 tumorigenic phenotype in hybrid cells formed from simian virus 40- and adenovirus 2-transformed hamster embryo cells. Patch CT; Hauser J; Lewis AM; Levine AS Cancer Res; 1983 Jun; 43(6):2571-5. PubMed ID: 6303562 [TBL] [Abstract][Full Text] [Related]
44. Phosphorylation of T antigen and p53 in carcinogen-treated SV40-transformed Chinese hamster cells. Paley EL Carcinogenesis; 1996 May; 17(5):939-45. PubMed ID: 8640941 [TBL] [Abstract][Full Text] [Related]
45. Nitrobenzo[a]pyrene-induced DNA amplification in SV40-transformed Chinese hamster embryo cells. Neft RE; Roe AL; Schol HM; Fu PP; Mittelstaedt RA; Casciano DA Environ Mol Mutagen; 1992; 19(2):156-60. PubMed ID: 1311674 [TBL] [Abstract][Full Text] [Related]
46. SV40 immortalization of adult human mesenchymal cells from neuroretina. Biological, functional and molecular characterization. Daya-Grosjean L; Azzarone B; Maunoury R; Zaech P; Elia G; Zaniratti S; Benedetto A Int J Cancer; 1984 Mar; 33(3):319-29. PubMed ID: 6321361 [TBL] [Abstract][Full Text] [Related]
47. Isolation and characterization of T antigen-negative revertants from a line of transformed rat cells containing one copy of the SV40 genome. Steinberg B; Pollack R; Topp W; Botchan M Cell; 1978 Jan; 13(1):19-32. PubMed ID: 202400 [TBL] [Abstract][Full Text] [Related]
48. Persistence of phage lambda DNA in genomes of mouse cells transformed by lambda-carrying SV40 vectors. Muzyczka N Gene; 1979 Jun; 6(2):107-22. PubMed ID: 225241 [TBL] [Abstract][Full Text] [Related]
49. Assignment of the integration site for simian virus 40 to chromosome 17 in GM54VA, a human cell line transformed by simian virus 40. Croce CM Proc Natl Acad Sci U S A; 1977 Jan; 74(1):315-8. PubMed ID: 189310 [TBL] [Abstract][Full Text] [Related]
50. Properties of T antigen-positive phenotypic revertants isolated from SV40-transformed rat and mouse cells. Maruyama K; Furuta T; Ueda K; Oda K Microbiol Immunol; 1982; 26(1):31-40. PubMed ID: 6283320 [TBL] [Abstract][Full Text] [Related]
51. Karyotype evolution of the human HBL-100 cell line and mapping of the integration site of SV40 DNA. Marlhens F; Saint-Ruf C; Nardeux P; Lavialle C; Brouty-Boye D; Dutrillaux B; Cassingena R Ann Genet; 1988; 31(2):81-6. PubMed ID: 2840847 [TBL] [Abstract][Full Text] [Related]
52. Carcinogen-mediated induction of SV40 DNA synthesis in SV40 transformed Chinese hamster embryo cells. Lavi S; Etkin S Carcinogenesis; 1981; 2(5):417-23. PubMed ID: 6268326 [TBL] [Abstract][Full Text] [Related]
53. Transformation by viruses: simian virus 40 as a model system. Noonan CA; Butel JS Natl Cancer Inst Monogr; 1978 May; (48):227-37. PubMed ID: 219355 [TBL] [Abstract][Full Text] [Related]
54. Carcinogen-mediated amplification of specific DNA sequences. Lavi S J Cell Biochem; 1982; 18(2):149-56. PubMed ID: 6279687 [TBL] [Abstract][Full Text] [Related]
55. Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen. Shay JW; Wright WE Exp Cell Res; 1989 Sep; 184(1):109-18. PubMed ID: 2551703 [TBL] [Abstract][Full Text] [Related]
56. Reversion of middle T antigen-transformed Rat-2 cells by Krev-1: implications for the role of p21c-ras in polyomavirus-mediated transformation. Jelinek MA; Hassell JA Oncogene; 1992 Sep; 7(9):1687-98. PubMed ID: 1380149 [TBL] [Abstract][Full Text] [Related]
57. [Immortalization of human fibroblasts using tsA mutant of SV40 and pSV3neo plasmid]. Inozemtseva LS; Chernikov VG; Manuilova ES; Marshak MI; Nikolaeva NP; Kulagina OS; Grivennikov IA Tsitologiia; 2001; 43(10):944-53. PubMed ID: 11769127 [TBL] [Abstract][Full Text] [Related]
58. [Genetic nature of one of the traits of malignant cell transformation in vitro]. Varshaver NB; Marshak MI; Shapiro NI Genetika; 1983 Jun; 19(6):981-7. PubMed ID: 6309612 [TBL] [Abstract][Full Text] [Related]
59. Membrane dynamic alteration associated with the tumorigenicity of polyoma-transformed and revertant hamster cells. Parola AH; Souroujon M Int J Cancer; 1979 Dec; 24(6):800-5. PubMed ID: 232495 [TBL] [Abstract][Full Text] [Related]
60. In vitro selection of SV40 T antigen epitope loss variants by site-specific cytotoxic T lymphocyte clones. Tanaka Y; Tevethia SS J Immunol; 1988 Jun; 140(12):4348-54. PubMed ID: 2453578 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]